Predictive Oncology Correlations

POAI Stock  USD 1.12  0.01  0.90%   
The current 90-days correlation between Predictive Oncology and GlucoTrack is -0.35 (i.e., Very good diversification). The correlation of Predictive Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Predictive Oncology Correlation With Market

PredictiveDowDiversified AwayPredictiveDowDiversified Away100%

Significant diversification

The correlation between Predictive Oncology and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Predictive Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.

Moving together with Predictive Stock

  0.84RVP Retractable Technologies Earnings Call This WeekPairCorr
  0.71MLSS Milestone Scientific Earnings Call This WeekPairCorr
  0.8PLX Protalix BiotherapeuticsPairCorr

Moving against Predictive Stock

  0.42VINC Vincerx Pharma Earnings Call This WeekPairCorr
  0.5ADVM Adverum BiotechnologiesPairCorr
  0.45ATNF 180 Life SciencesPairCorr
  0.41INBX Inhibrx Symbol ChangePairCorr
  0.37ZURA Zura Bio LimitedPairCorr
  0.36MLTX MoonLake ImmunotherapeutiPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
BNGOSTSS
NXGLGCTK
STSSGCTK
BNGOGCTK
LUCYSTSS
BNGOLUCY
  
High negative correlations   
ISRGPDEX
NXGLMBOT
MBOTGCTK
ISRGGCTK
PDEXMBOT
MBOTSTSS

Risk-Adjusted Indicators

There is a big difference between Predictive Stock performing well and Predictive Oncology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Predictive Oncology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
GCTK  9.27 (3.33) 0.00 (6.57) 0.00 
 19.55 
 77.82 
GMVD  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
STSS  9.25 (2.47) 0.00  0.81  0.00 
 19.35 
 76.46 
MBOT  7.29  1.50  0.18  1.04  7.33 
 16.23 
 121.64 
NXGL  3.68 (0.51) 0.00 (0.24) 0.00 
 7.46 
 23.35 
PDEX  3.76  0.21  0.05  0.25  4.14 
 8.67 
 34.56 
LUCY  4.04 (0.93) 0.00 (0.99) 0.00 
 7.18 
 28.66 
ZJYL  6.60  0.31  0.03  0.13  8.23 
 14.61 
 52.20 
BNGO  5.63 (1.88) 0.00  12.17  0.00 
 7.60 
 64.93 
ISRG  1.55 (0.04) 0.00 (0.07) 0.00 
 2.28 
 14.53 

Predictive Oncology Corporate Management

Joshua MBAInterim OfficerProfile
BS BScVP RDProfile
Pamela MBAChief OfficerProfile
Raymond VennareCEO ChairmanProfile
DSc ODVP OperationsProfile
Julia KirshnerChief OfficerProfile